A new microemulsion formulation of cyclosporin (Neoral) is effective in the treatment of cyclosporin-resistant dermatoses
- PMID: 8733391
- DOI: 10.1111/j.1365-2133.1996.tb06990.x
A new microemulsion formulation of cyclosporin (Neoral) is effective in the treatment of cyclosporin-resistant dermatoses
Abstract
Cyclosporin is a highly effective treatment for severe psoriasis and atopic dermatitis. However, both inter- and intrapatient gastrointestinal absorption of the conventional formulation of cyclosporin (Sandimmun) are very variable, ranging from 20 to 50%. Variations in bioavailability may explain isolated resistance to therapy. Neoral is a novel microemulsion formulation of cyclosporin which has been developed to enhance and standardize its absorption. We report the first experience with Neoral in patients with psoriasis and atopic dermatitis refractory to Sandimmun.
Similar articles
-
Neoral (cyclosporin) in dermatology: technical aspects.Br J Dermatol. 1996 Sep;135 Suppl 48:2-4. doi: 10.1111/j.1365-2133.1996.tb00701.x. Br J Dermatol. 1996. PMID: 8881896 Review.
-
Increased bioavailability and improved efficacy, in severe psoriasis, of a new microemulsion formulation of cyclosporin.Br J Dermatol. 1996 Sep;135 Suppl 48:35-9. doi: 10.1111/j.1365-2133.1996.tb00708.x. Br J Dermatol. 1996. PMID: 8881903 Clinical Trial.
-
Clinical aspects: preliminary experience with a novel oral formulation of cyclosporin (Neoral).Br J Dermatol. 1996 Sep;135 Suppl 48:5-8. doi: 10.1111/j.1365-2133.1996.tb00702.x. Br J Dermatol. 1996. PMID: 8881897 Clinical Trial.
-
Comparison of the steady state pharmacokinetics of two formulations of cyclosporin in patients with atopic dermatitis.Br J Dermatol. 1996 Sep;135 Suppl 48:9-14. doi: 10.1111/j.1365-2133.1996.tb00703.x. Br J Dermatol. 1996. PMID: 8881898 Clinical Trial.
-
Cyclosporin: an updated review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (neoral)1 in organ transplantation.Drugs. 2001;61(13):1957-2016. doi: 10.2165/00003495-200161130-00006. Drugs. 2001. PMID: 11708766 Review.
Cited by
-
Quality of life improvement in treatment of psoriasis with intermittent short course cyclosporin (Neoral).Qual Life Res. 2004 Feb;13(1):91-5. doi: 10.1023/B:QURE.0000015293.69661.ff. Qual Life Res. 2004. PMID: 15058791
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
